Miranda Jayne Toledano
Chief Executive Officer at Entera Bio Ltd.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Entera Bio Ltd., 3 years.
Entera Bio Ltd.
Director · Chief Executive Officer
Journey Medical Corporation
Director
NexGel Inc
Director
Chief executive roles
Entera Bio Ltd.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | Entera Bio Ltd. | Grant or award | +347,567 | — | — |
| Jul 14, 2026 | Entera Bio Ltd. | Grant or award | +72,993 | — | — |
| Jul 1, 2026 | Journey Medical Corporation | Grant or award | +50,000 | — | — |
| Jun 25, 2026 | Journey Medical Corporation | Grant or award | +10,000 | — | — |
| Dec 29, 2025 | Entera Bio Ltd. | Open-market purchase | +11,000 | $1.81 | $19,910 |
| Aug 5, 2025 | Journey Medical Corporation | Grant or award | +20,000 | — | — |
| Jul 16, 2025 | Entera Bio Ltd. | Grant or award | +136,842 | — | — |
| Jul 16, 2025 | Entera Bio Ltd. | Grant or award | +43,860 | — | — |
| Jun 25, 2025 | Journey Medical Corporation | Grant or award | +7,173 | — | — |
| Jul 31, 2024 | Entera Bio Ltd. | Grant or award | +124,121 | — | — |
| Jul 8, 2024 | Journey Medical Corporation | Grant or award | +9,728 | — | — |
| Dec 22, 2023 | Entera Bio Ltd. | Open-market purchase | +23,952 | $0.71 | $17,006 |
| Jul 21, 2023 | Journey Medical Corporation | Grant or award | +27,472 | — | — |
| Apr 4, 2023 | Entera Bio Ltd. | Open-market purchase | +30,000 | $1.01 | $30,300 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.